Glenmark Life Sciences (GLS.NSE) Q3 2025 Earnings

1AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
7.63
8.95
10.27
11.6

Details

Expected EPS
11.07557931024
Actual EPS
9.85624947792
Surprise EPS
-1.22
Surprise Percent
+11.01%

Description

Glenmark Life Sciences (GLS.NSE) has reported earnings of 9.85624947792 per share for Q3 2025.

0 Comments

Share your thoughts